OVERVIEW

Eyeforpharma Japan virtual 2020 is organized by eyeforpharma. This Online CME conference will be held from Sep 01 - 04, 2020.

What is the purpose of Eyeforpharma Japan virtual 2020? 

Course Description:
From the Opening Keynote, concentrating on the future direction of pharma with cutting-edge case studies, to the practical themes covering Digital Clinical Innovation, Commercial Excellence, Medical Affairs & RWE, we will remit a novel direction for your planning.

Commercial excellence:
Commercial pharma conference has 3 Essential themes:
• Digital transformation - Understand the requirement to digitize. Learn about innovative technologies. Focus on value with partnerships that deliver holistic patient outcomes.
• New commercial excellence models - Remodel your business model by ensuring you act decisively on customer insights. Utilize data to gain insights to engage HCPs in a smart way.
• Deliver patient value to drive commercial & medical excellence - Verify the authenticity of your medicine and care provision with robust data and a great story for HCPs and patient outcomes.

RWE & Data:
RWE & Medical has 4 Essential themes:

Prove the authenticity of your medicine and care provision - Assure all communication from medical affairs is supported by real-world evidence
Strategic communication - Help the organization to recognize and make decisions based on high-quality, evidence-based, contextual information
Be the patient champion - Identify and communicate penetrations both internally and externally from consistent, genuine patient engagement
Digitize medical affairs - Build an agile, flexible organization to deliver for the right customer with the right product at the right time

Additional details will be posted as soon as information is available.

SPECIALITIES

OphthalmologyPharmacy and Medicine

TERMS & CONDITIONS

 

RELATED ONLINE COURSES

Webcast

Ophthalmology
2.5 AAPA
More actions
US$299

Webcast

Emergency Medicine
More actions
US$200

Webcast

Pediatrics
28 AMA PRA Category 1 Credits™
More actions
US$910